PubMed · 2004 · 15 citations · 19 references
MedicineCardiologyCardiovascular PharmacotherapyLipid BiochemistryPreventive CardiologyCardiovascular DiseaseEndothelial DysfunctionLipid DisordersLipid-lowering TherapyLipoprotein MetabolismAtherosclerosis RiskCarotid Artery AtherosclerosisEndothelial Dysfunction AssessmentFlow-mediated VasodilationPlasma Cholesterol LevelsVascular Endothelial Dysfunction
Atherogenic lipoproteins can cause endothelial dysfunction in the initial stage of atherogenesis. In our study we examined 134 patients with defined hyperlipoproteinemia (non-HDL cholesterol>4.1 mmol/l or triglycerides>2.5 mmol/l or taking any of lipid lowering drugs)--94 men and 40 women. The subgroup of controls of comparable age contained 54 normolipidemic individuals--30 men and 24 women. Patients with hyperlipoproteinemia revealed significantly lower ability of endothelium-dependent flow-mediated vasodilation (EDV) measured on brachial artery (4.13+/-3.07 vs. 5.41+/-3.82 %; p=0.032) and higher carotid intima media thickness than normolipidemic controls (0.68+/-0.22 vs. 0.58+/-0.15 mm; p=0.005). In regression analysis, EDV correlated significantly with plasma concentrations of oxLDL (p<0.05) HDL-cholesterol (p<0.05), Apo A1 (p<0.05), ATI (p<0.01) and non-HDL cholesterol (p<0.05). Patients with hyperlipoproteinemia showed higher plasma levels of oxLDL (65.77+/-9.54 vs. 56.49+/-7.80 U/l; p=0.015), malondialdehyde (0.89+/-0.09 vs. 0.73+/-0.08 micromol/l; p=0.010) and nitrites/nitrates (20.42+/-4.88 vs. 16.37+/-4.44 micromol/l; p=0.018) indicating possible higher long-term oxidative stress in these patients.
19
Body Iron Stores and the Risk of Carotid Atherosclerosis
Stefan Kiechl, Johann Willeit, Georg Egger et al. · Circulation · 1997 · 396 citations
Medicine, Cardiology, Inflammation +13
Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men
Tomi‐Pekka Tuomainen, Kari Punnonen, Kristiina Nyyssönen et al. · Circulation · 1998 · 287 citations
Medicine, Cardiology, Hematology +17